Roggenbuck, Dirk

Autoantibody diagnostics in clinical practice

Conrad, K., Roggenbuck, D., Reinhold, D., & Sack, U. (2012) · Autoimmunity Reviews

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 64

Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis

Wunsch, E., Norman, G. L., Milkiewicz, M., Krawczyk, M., Bentow, C., Shums, Z., Mahler, M., Lopens, S., Reinhold, D., Franke, A., et al. (2021) · Alimentary Pharmacology & Therapeutics

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 43

Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper

Bossuyt, X., Damoiseaux, J., Rasmussen, N., van Paassen, P., Hellmich, B., Baslund, B., Blockmans, D., Vermeersch, P., Lopez-Hoyos, M., Vercammen, M., et al. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM)

Vasculitis and related conditionsClinical Laboratory Practices and Quality Control

Cited by 29

High Sensitive Detection of Double‐Stranded DNA Autoantibodies by a Modified Crithidia luciliae Immunofluorescence Test

Conrad, K., Ittenson, A., Reinhold, D., Fischer, R., Roggenbuck, D., Büttner, T., Bosselmann, H., Steinbach, J., & Schößler, W. (2009) · Annals of the New York Academy of Sciences

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 27

THU-095 Novel machine learning algorithm for risk prediction of cholangiocarcinoma in primary sclerosing cholangitis

Wunsch, E., Horecki, M., Milkiewicz, M., Kruk, B., Fischer, K., Winikajtis-Burzyńska, A., Norman, G., Roggenbuck, D., & Milkiewicz, P. (2024) · Journal of Hepatology

Liver Diseases and ImmunityCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 1